TNF and rheumatoid arthritis: When examined as response following TIV, similar to the serum antibody response, the frequency of RA patients treated with anti-TNF that had a four-fold or greater increase in TIV-specific memory B cells at one month post-vaccination was significantly lower than both the HC and RA groups.